Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-19-028290

Options or other derivatives

  • Director acquired 23,684 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mathers Edward T Director 2019-05-07 Grant or award · Stock Option (right to buy) +23,684 23,684 D: show line 1 in the form
Loading xslF345X03/doc4.xml…